Intuitive Surgical, Inc. Cost of Revenue
Intuitive Surgical, Inc. (ISRG) reported Cost of Revenue of $931.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-21
- Intuitive Surgical, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $931.90M, a 13.36% increase year-over-year.
- Intuitive Surgical, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $940.30M, a 18.17% increase year-over-year.
- Intuitive Surgical, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $961.90M, a 24.71% increase year-over-year.
- Intuitive Surgical, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $842.70M, a 26.87% increase year-over-year.
- Intuitive Surgical, Inc. cost of goods and services sold for fiscal 2025 was $3.42B, a 25.92% increase from fiscal 2024.
- Intuitive Surgical, Inc. cost of goods and services sold for fiscal 2024 was $2.72B, a 13.50% increase from fiscal 2023.
- Intuitive Surgical, Inc. cost of goods and services sold for fiscal 2023 was $2.39B, a 18.18% increase from fiscal 2022.
- Intuitive Surgical, Inc. cost of goods and services sold for fiscal 2022 was $2.03B, a 15.68% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $931.90M 10-Q · filed 2026-07-21 | $1.87B 10-Q · filed 2026-07-21 | $2.83B derived: sum of 3 quarters · filed 2026-07-21 | $3.68B derived: sum of 4 quarters · filed 2026-07-21 |
| 2026-03-31 | $940.30M 10-Q · filed 2026-04-22 | $1.90B derived: sum of 2 quarters · filed 2026-04-22 | $2.74B derived: sum of 3 quarters · filed 2026-04-22 | $3.57B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-12-31 | $961.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.80B derived: sum of 2 quarters · filed 2026-02-03 | $2.63B derived: sum of 3 quarters · filed 2026-07-21 | $3.42B 10-K · filed 2026-02-03 |
| 2025-09-30 | $842.70M 10-Q · filed 2025-10-22 | $1.66B derived: sum of 2 quarters · filed 2026-07-21 | $2.46B 10-Q · filed 2025-10-22 | $3.23B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-06-30 | $822.10M 10-Q · filed 2026-07-21 | $1.62B 10-Q · filed 2026-07-21 | $2.39B derived: sum of 3 quarters · filed 2026-07-21 | $3.05B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-03-31 | $795.70M 10-Q · filed 2026-04-22 | $1.57B derived: sum of 2 quarters · filed 2026-04-22 | $2.23B derived: sum of 3 quarters · filed 2026-04-22 | $2.87B derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | $771.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.44B derived: sum of 2 quarters · filed 2026-02-03 | $2.07B derived: sum of 3 quarters · filed 2026-02-03 | $2.72B 10-K · filed 2026-02-03 |
| 2024-09-30 | $664.20M 10-Q · filed 2025-10-22 | $1.30B derived: sum of 2 quarters · filed 2025-10-22 | $1.95B 10-Q · filed 2025-10-22 | $2.60B derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | $637.20M 10-Q · filed 2025-07-23 | $1.28B 10-Q · filed 2025-07-23 | $1.93B derived: sum of 3 quarters · filed 2026-02-03 | $2.51B derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $645.20M 10-Q · filed 2025-04-23 | $1.30B derived: sum of 2 quarters · filed 2026-02-03 | $1.87B derived: sum of 3 quarters · filed 2026-02-03 | $2.46B derived: sum of 4 quarters · filed 2026-02-03 |
| 2023-12-31 | $650.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.23B derived: sum of 2 quarters · filed 2026-02-03 | $1.81B derived: sum of 3 quarters · filed 2026-02-03 | $2.39B 10-K · filed 2026-02-03 |
| 2023-09-30 | $576.50M 10-Q · filed 2024-10-18 | $1.16B derived: sum of 2 quarters · filed 2024-10-18 | $1.74B 10-Q · filed 2024-10-18 | $2.29B derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-06-30 | $584.00M 10-Q · filed 2024-07-19 | $1.17B 10-Q · filed 2024-07-19 | $1.71B derived: sum of 3 quarters · filed 2025-01-31 | $2.22B derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-03-31 | $583.20M 10-Q · filed 2024-04-19 | $1.13B derived: sum of 2 quarters · filed 2025-01-31 | $1.63B derived: sum of 3 quarters · filed 2025-01-31 | $2.13B derived: sum of 4 quarters · filed 2025-01-31 |
| 2022-12-31 | $544.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $1.05B derived: sum of 2 quarters · filed 2025-01-31 | $1.55B derived: sum of 3 quarters · filed 2025-01-31 | $2.03B 10-K · filed 2025-01-31 |
| 2022-09-30 | $505.30M 10-Q · filed 2023-10-20 | $1.00B derived: sum of 2 quarters · filed 2023-10-20 | $1.48B 10-Q · filed 2023-10-20 | $1.97B derived: sum of 4 quarters · filed 2024-01-31 |
| 2022-06-30 | $498.80M 10-Q · filed 2023-07-24 | $976.80M 10-Q · filed 2023-07-24 | $1.47B derived: sum of 3 quarters · filed 2024-01-31 | $1.90B derived: sum of 4 quarters · filed 2024-01-31 |
| 2022-03-31 | $478.00M 10-Q · filed 2023-04-20 | $967.90M derived: sum of 2 quarters · filed 2024-01-31 | $1.40B derived: sum of 3 quarters · filed 2024-01-31 | $1.84B derived: sum of 4 quarters · filed 2024-01-31 |
| 2021-12-31 | $489.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $921.80M derived: sum of 2 quarters · filed 2024-01-31 | $1.36B derived: sum of 3 quarters · filed 2024-01-31 | $1.75B 10-K · filed 2024-01-31 |
| 2021-09-30 | $431.90M 10-Q · filed 2022-10-21 | $872.20M derived: sum of 2 quarters · filed 2022-10-21 | $1.26B 10-Q · filed 2022-10-21 | $1.70B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $440.30M 10-Q · filed 2022-07-22 | $829.80M 10-Q · filed 2022-07-22 | $1.26B derived: sum of 3 quarters · filed 2023-02-10 | $1.62B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $389.50M 10-Q · filed 2022-04-22 | $822.80M derived: sum of 2 quarters · filed 2023-02-10 | $1.18B derived: sum of 3 quarters · filed 2023-02-10 | $1.53B derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $433.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $786.70M derived: sum of 2 quarters · filed 2023-02-10 | $1.14B derived: sum of 3 quarters · filed 2023-02-10 | $1.50B 10-K · filed 2023-02-10 |
| 2020-09-30 | $353.40M 10-Q · filed 2021-10-20 | $702.60M derived: sum of 2 quarters · filed 2021-10-20 | $1.06B 10-Q · filed 2021-10-20 | $1.45B derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-06-30 | $349.20M 10-Q · filed 2021-07-21 | $710.50M 10-Q · filed 2021-07-21 | $1.09B derived: sum of 3 quarters · filed 2022-02-03 | $1.43B derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-03-31 | $361.30M 10-Q · filed 2021-04-21 | $743.00M derived: sum of 2 quarters · filed 2022-02-03 | $1.09B derived: sum of 3 quarters · filed 2022-02-03 | $1.43B derived: sum of 4 quarters · filed 2022-02-03 |
| 2019-12-31 | $381.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $724.30M derived: sum of 2 quarters · filed 2022-02-03 | $1.06B derived: sum of 3 quarters · filed 2022-02-03 | $1.37B 10-K · filed 2022-02-03 |
| 2019-09-30 | $342.60M 10-Q · filed 2020-10-19 | $682.50M derived: sum of 2 quarters · filed 2020-10-19 | $986.60M 10-Q · filed 2020-10-19 | $1.30B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $339.90M 10-Q · filed 2020-07-23 | $644.00M 10-Q · filed 2020-07-23 | $954.80M derived: sum of 3 quarters · filed 2021-02-10 | $1.23B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $304.10M 10-Q · filed 2020-04-17 | $614.90M derived: sum of 2 quarters · filed 2021-02-10 | $893.50M derived: sum of 3 quarters · filed 2021-02-10 | $1.17B derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $310.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $589.40M derived: sum of 2 quarters · filed 2021-02-10 | $866.40M derived: sum of 3 quarters · filed 2021-02-10 | $1.12B 10-K · filed 2021-02-10 |
| 2018-09-30 | $278.60M 10-Q · filed 2019-10-18 | $555.60M derived: sum of 2 quarters · filed 2019-10-18 | $809.30M 10-Q · filed 2019-10-18 | $1.07B derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-06-30 | $277.00M 10-Q · filed 2019-07-22 | $530.70M 10-Q · filed 2019-07-22 | $788.70M derived: sum of 3 quarters · filed 2020-02-07 | $1.03B derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-03-31 | $253.70M 10-Q · filed 2019-04-19 | $511.70M derived: sum of 2 quarters · filed 2020-02-07 | $751.40M derived: sum of 3 quarters · filed 2020-02-07 | |
| 2017-12-31 | $258.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $497.70M derived: sum of 2 quarters · filed 2020-02-07 | $936.20M 10-K · filed 2020-02-07 | |
| 2017-09-30 | $239.70M 10-Q · filed 2018-10-22 | $678.20M 10-Q · filed 2018-10-22 | ||
| 2016-12-31 | $813.60M 10-K · filed 2019-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |